Main Article Content
pregnancy, iron deficiency anaemia, intravenous iron sucrose
Background: The World Health Organization refers to this condition as anemia when hemoglobin is less than 11 gram/dl and hematocrit is less than 33. It is also known as the most common medical disorder in pregnancy. Anaemia is indirectly responsible for 40 percent to 50 percent of maternal deaths, especially in developing countries. All around the world, the most common cause of anaemia in pregnancy is a deficiency of iron. If anaemia is severe in pregnancy, there are poor maternal and fetal results. Preeclampsia, postpartum haemorrhage, preterm labor, sepsis, and an increase in the need for blood transfusion are some maternal effects.
Objective: The aim of this research is to identify the efficiency of intravenous iron sucrose in anaemic pregnant women.
Study design: A cross-sectional study
Place and Duration This study was conducted in Sandeman Provisional Hospital Quetta from March 2022 to March 2023
Methodology: All of the patients were aged between 20 years to 38 years. All of these participants were presented at the outpatient clinic with a singleton fetus and a gestational age of 26–34 weeks by checking through ultrasound. All of the participants were diagnosed with hypochromic microcytic anaemia, which was identified through blood examination. The target haemoglobin was 11g/dl. An intravenous injection was used to give iron sucrose on alternative days. Haemoglobin was repeated after 3 weeks of the last dose of intravenous iron.
Results: There were a total of 120 people selected for this research. A large number of participants were between 26 and 30 years old. The average age calculated was 32.3 years. A total of 60% of the cases were those whose gestational age was 31 to 34 weeks. At the end, the treatment was effective for 90 (75%) of the total participants.
Conclusion: The iron sucrose complex effectively elevated haemoglobin to an acceptable level in severely anaemic, iron-deficient pregnant women, demonstrating safety and good tolerance.
2. Wali A, Mushtaq A. Comparative study--efficacy, safety and compliance of intravenous iron sucrose and intramuscular iron sorbitol in iron deficiency anemia of pregnancy. Journal of Pakistan Medical Association. 2002;52(9):392.
3. Sharma J, Tiwari S. Intravenous iron sucrose therapy in iron deficiency anemia in antenatal and postnatal patients. JNMA J Nepal Med Assoc. 2015 Apr 1;53:104-7.
4. Swami MB, Tiwari N, Sharma P. Intravenous iron sucrose therapy in anemia with pregnancy. Journal of Evolution of Medical and Dental Sciences. 2015 Aug 24;4(68):11850-7.
5. Singh A, Singh S, Sharma A. The study of efficacy of injection iron sucrose in treatment of iron deficiency anemia in pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2019 Jun 1;8(6):2444-9.
6. Gaikwad HS, Sindhu A, Sarda N. Comparison of efficacy and safety of intravenous iron sucrose and intramuscular iron sorbitol therapy in patients with anemia during pregnancy in a developing country. Asian Journal of Medical Sciences. 2017 Aug 31;8(5):31-5.
7. Gupta A, Manaktala U, Rathore AM. A randomised controlled trial to compare intravenous iron sucrose and oral iron in treatment of iron deficiency anemia in pregnancy. Indian Journal of Hematology and Blood Transfusion. 2014 Jun;30:120-5.
8. Kriplani A, Mahey R, Dash BB, Kulshreshta V, Agarwal N, Bhatla N. Intravenous iron sucrose therapy for moderate to severe anaemia in pregnancy. The Indian journal of medical research. 2013 Jul;138(1):78.
9. Garg A, Agarwal M, Shankar U, Shetty S. Comparative study of oral iron and intravenous iron sucrose for the treatment of iron deficiency anemia in pregnancy. International Journal of Reproduction, Contraception, Obstetrics and Gynecology. 2017 Jan 1;6(1):172-6.
10. Kondrakunta DR. Study of efficacy and compliance of iron sucrose in iron deficiency anaemia in pregnancy. Int J Clin Obstet Gynaecol. 2021;5(5):170-4.
11. Sharma JB. Nutritional anaemia during pregnancy in non-industrialized countries: Progress in obstetrics and gynaecology. 15th ed. Spain: Churchill Livingstone; 2003. P.103-11
12. Kalaivani K. Prevalence & consequences of anaemia in pregnancy. Indian J Med Res. 2009 Nov;130(5):627- 33.
13. Habib F, Alabdin EH, Alenazy M, Nooh R. Compliance to iron supplementation during pregnancy. J Obstet Gynaecol. 2009 Aug;29(6):487-92.
14. Bhutta ZA, Rizvi A, Raza F, Hotwani S, Zaidi S, Moazzam Hossain S, Soofi S, Bhutta S. A comparative evaluation of multiple micronutrient and iron-folic acid supplementation during pregnancy in Pakistan: impact on pregnancy outcomes. Food Nutr Bull. 2009 Dec;30(4):S496-505.
15. Bozhinova S. Treatment of iron deficiency anaemia in pregnant, puerperal and gynaecological patientsdifferent drugs, different approaches. Akush Ginekol (Sofiia) 2005; 44: 46-50
16. Gupta K, Arnold F, Kishor S, Parasuraman S. Concern on prevalence of anaemia in pregnant & lactating women in India. Indian J Med Res 2007;125:99-101.
17. Breymann C. Iron deficiency and anaemia in pregnancy: modern aspects of diagnosis and therapy. Blood Cells Mol Dis 2002; 29: 506-16.
18. Komolafe JO, Kuti O, Ijadunola KT, Ogunniyi SO. A comparative study between intramuscular iron dextran and oral ferrous sulphate in the treatment of iron deficiency anaemia in pregnancy. J Obstet Gynaecol 2003;23:628-31.
19. Goodnough LT, Skikne B, Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 2000; 96: 823-33.
20. Mungen E. Iron supplementation in pregnancy. J Perinat Med 2003; 31: 420-6.